Clinical Trial Update: Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

View source ↗

Summary

A retrospective, multi-indication study sponsored by Optimata Ltd. to validate PrediCare's ability to predict Time To Progression in cancer patients under stand…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Optimata Ltd. | Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer | Status: UNKNOWN